Effect of IV Dexamethasone on Post-op Urinary Retention After Spinal Anesthesia

NAActive, not recruitingINTERVENTIONAL
Enrollment

1,084

Participants

Timeline

Start Date

August 20, 2025

Primary Completion Date

January 1, 2026

Study Completion Date

January 20, 2026

Conditions
Post Operative Urinary RetentionSpinal Aneshtesia
Interventions
DRUG

Dexamethasone (IV)

Intravenous administration of 8 mg dexamethasone sodium phosphate given as a single dose before surgery under spinal anesthesia. This corticosteroid is being evaluated for its potential to prevent postoperative urinary retention (POUR) by reducing inflammation and other perioperative effects.

DRUG

Normal Saline (0.9% NaCl)

Intravenous administration of 0.9% normal saline (placebo) given as a single dose before surgery under spinal anesthesia. This inert solution is used to compare against the active drug dexamethasone to determine its effect on postoperative urinary retention (POUR).

Trial Locations (1)

9710000

Al-Makassed Islamic Charitable Society Hospital, East Jerusalem

All Listed Sponsors
lead

Al-Quds University

OTHER